Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Current Assets (2020 - 2025)

Historic Current Assets for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $110.1 million.

  • Oncology Institute's Current Assets fell 543.96% to $110.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.1 million, marking a year-over-year decrease of 543.96%. This contributed to the annual value of $112.4 million for FY2024, which is 2165.61% down from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Current Assets is $110.1 million, which was down 543.96% from $104.8 million recorded in Q2 2025.
  • Oncology Institute's 5-year Current Assets high stood at $154.1 million for Q4 2021, and its period low was $287110.0 during Q3 2021.
  • Over the past 5 years, Oncology Institute's median Current Assets value was $116.2 million (recorded in 2024), while the average stood at $105.7 million.
  • Per our database at Business Quant, Oncology Institute's Current Assets tumbled by 7608.93% in 2021 and then surged by 4992647.07% in 2022.
  • Oncology Institute's Current Assets (Quarter) stood at $154.1 million in 2021, then fell by 15.34% to $130.4 million in 2022, then increased by 10.03% to $143.5 million in 2023, then dropped by 21.66% to $112.4 million in 2024, then dropped by 2.07% to $110.1 million in 2025.
  • Its last three reported values are $110.1 million in Q3 2025, $104.8 million for Q2 2025, and $106.8 million during Q1 2025.